Listed

CVS HEALTH Corp: Form 10-Q for the period ended Jun 30, 2011

Filed with the SEC on Aug 4, 2011 and accepted by EDGAR at Aug 4, 2011, 16:05 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2011-04-01 to 2011-06-30$26.63bnus-gaap:Revenues
Revenue6 months2011-01-01 to 2011-06-30$52.51bnus-gaap:Revenues
Cost of revenue3 months2011-04-01 to 2011-06-30$21.53bnus-gaap:CostOfRevenue
Cost of revenue6 months2011-01-01 to 2011-06-30$42.66bnus-gaap:CostOfRevenue
Gross profit3 months2011-04-01 to 2011-06-30$5.09bnus-gaap:GrossProfit
Gross profit6 months2011-01-01 to 2011-06-30$9.85bnus-gaap:GrossProfit
Operating income3 months2011-04-01 to 2011-06-30$1.49bnus-gaap:OperatingIncomeLoss
Operating income6 months2011-01-01 to 2011-06-30$2.80bnus-gaap:OperatingIncomeLoss
Interest expense3 months2011-04-01 to 2011-06-30$149.0mus-gaap:InterestExpense
Interest expense6 months2011-01-01 to 2011-06-30$284.0mus-gaap:InterestExpense
Income tax3 months2011-04-01 to 2011-06-30$526.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2011-01-01 to 2011-06-30$990.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2011-04-01 to 2011-06-30$816.0mus-gaap:NetIncomeLoss
Net income6 months2011-01-01 to 2011-06-30$1.53bnus-gaap:NetIncomeLoss
Diluted EPS3 months2011-04-01 to 2011-06-30$0.60us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2011-01-01 to 2011-06-30$1.12us-gaap:EarningsPerShareDiluted
Basic EPS3 months2011-04-01 to 2011-06-30$0.60us-gaap:EarningsPerShareBasic
Basic EPS6 months2011-01-01 to 2011-06-30$1.13us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2011-04-01 to 2011-06-301,364,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2011-01-01 to 2011-06-301,368,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2011-01-01 to 2011-06-30$3.07bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2011-01-01 to 2011-06-30$710.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2011-01-01 to 2011-06-30$341.0mus-gaap:PaymentsOfDividends
Share repurchases6 months2011-01-01 to 2011-06-30$971.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2011-06-30$2.23bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-06-30$19.07bnus-gaap:AssetsCurrent
Total assetsAt period end2011-06-30$65.49bnus-gaap:Assets
Current liabilitiesAt period end2011-06-30$11.75bnus-gaap:LiabilitiesCurrent
Long-term debtAt period end2011-06-30$10.17bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2011-06-30$916.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2011-06-30$38.24bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-11-043697. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.